Interrelationship of age, depression, and central serotonergic function: Evidence from fenfluramine challenge studies

International Psychogeriatrics

Volumn 8, Issue 1, 1996, Pages 83-102

  Lerer, Bernard ^a,b   Gillon, Dan ^a   Lichtenberg, Pesach ^b,d   Gorfine, Malka ^b,c   Gelfin, Yevgenia ^a,b   Shapira, Baruch ^b,d  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d HERZOG HOSPITAL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FENFLURAMINE; HYDROCORTISONE; PROLACTIN; SEROTONIN;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE PREDISPOSITION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; NEUROBIOLOGY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; FENFLURAMINE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PROLACTIN; REFERENCE VALUES; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS;

EID: 0029990720     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610296002499     Document Type: Article

References (51)

1. Allen, S. J., Benton, J. S., Goodhardt, M. J., Haan, E. A., Sims, N. R., et al. (1983). Biochemical evidence of selective nerve cell changes in the normal aging human and rat brain. Journal of Neurochemistry, 41, 256-265.
2. Asberg, M., Schalling, D., Traskman-Bendz, L., & Wagner, A. (1987). Psychobiology of suicide, impulsivity, and related phenomena. In H. Y. Meltzer (Ed.), Psychophannacology. The third generation of progress (pp. 655-668). New York: Raven Press.
3. Burke, K. C., Burke, J. D., Regier, D. A., & Rae, D. S. (1990). Age at onset of selected mental disorders in five community populations. Archives of General Psychiatry, 47, 511-518.
4. Chaouloff, F. (1993). Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Research Reviews, 18, 1-32.
5. Charney, D. S., Menekes, D. B., & Heninger, G. R. (1981). Receptor sensitivity and the mechanism of action of antidepressant treatment. Archives of General Psychiatry, 38, 1160-1180.
6. Coccaro, E. F., Siever, L. J., Klar, H. M., Maurer, G., Cochrane, K., et al. (1989). Serotonergic studies in patients with affective and personality disorders. Archives of General Psychiatry, 46, 587-599.
7. Coppen, A. (1967). The biochemistry of affective disorders. British Journal of Psychiatry, 113, 1237-1264.
8. Costa, E. A., Gropetti, A., & Refuelta, A. (1971). Action of fenfluramine on monoamine stores of rat tissue. British Journal of Pharmacology, 41, 57-64.
9. Cowen, P. J., Parry-Billings, M., & Newsholme, E. A. (1989). Decreased plasma tryptophan levels in major depression. Journal of Affective Disorders, 16, 27-31.
10. Delgado, P. L., Charney, D. S., Price, L. H., Aghajanian, G. K., Landis, H., et al. (1990). Serotonin function and the mechanism of antidepressant action: Reversal of antidepressant induced remission by rapid depletion of plasma tryptophan. Archives of General Psychiatry, 47, 411-418.
11. Direnzo, G., Amoroso, S., Taglialotela, M., Canzoniero, L., Basile, V., et al. (1989). Pharmacological characterisation of serotonin receptors involved in the control of prolactin secretion. European Journal of Pharmacology, 162, 371-373.
12. Fuxe, K., Farnebo, L. O., Hamberger, B., & Ogren, S. O. (1975). On the in vivo and in vitro actions of fenfluramine and its derivatives on central monoamine neurons, especially 5-hydroxtryptamine neurons, and their relation to the anorectic activity of fenfluramine. Postgraduate Medical Journal, 551(Suppl. 1), 35-45.
13. Golden, R. N., Hsiao, J. K., Lane, E., Ekstrom, D., Rogers, S., et al. (1990). Abnormal neuroendocrine responsivity to acute IV clomipramine challenge in depressed patients. Psychiatry Research 31, 39-47.
14. Goodall, E. M., Cowen, P. J., Franklin, M., & Silverstone, T. (1993). Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers. Psychopharmacology, 112, 461-466.
15. Goodwin, F. K., & Jamison, K. R. (1989). Manic-depressive illness. New York: Oxford University Press.
16. 2 receptors in the human brain postmortem. Brain Research, 519, 223-227.
17. Guy, W. (1976). ECDEU assessment manual for psychopharmacology (pp. 217-222). Rockville, MD: National Institute of Mental Health.
18. Hagnell, O., Lanke, J., Rorsman, B., & Ojesjo, L. (1982). Are we entering an age of melancholy? Depressive illness in a prospective epidemiological study over 25 years: The Lundby study, Sweden. Psychological Medicine, 12, 279-282.
19. Heninger, G. R., & Charney, D. S. (1987). Mechanism of action of antidepressant treatments: Implications for the etiology and treatment of depressive disorders. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress (pp. 535-544). New York: Raven Press.
20. Heninger, G. R., Charney, D. S., & Sternberg, D. E. (1984). Serotonergic function in depression: Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. Archives of General Psychiatry, 41, 398-402.
21. Invemizzi, R., Kmjeciak-Kolada, K., & Samanin, R. (1982). Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptophan in the rat brain? British Journal of Pharmacology, 75, 525-530.
22. Jacobs, L. S., Snyder, P. J., Utiger, R. G., & Daughaday, W. H. (1973). Prolactin response to thyrotropin releasing hormone in normal subjects. Journal of Clinical Endocrinology and Metabolism, 36, 1069-1073.
23. Lapin, I. P., & Oxenkrug, G. F. (1969). Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effect Lancet, 1, 132-136.
24. Lerer, B., Hanin, B., Kallian, M., Shapira, B., Bloch, M., et al. (1994). Early parental loss and recent bereavement in patients hospitalised for major depression. Neuropsychopharmacology, 10, 94-95.
25. Lerer, B., Ran, A., Blacker, M., Silver, H., Weller, M. P. I., et al. (1988). Neuroendocrine responses in chronic schizophrenia: Evidence for serotonergic dysfunction. Schizophrenia Research, 1, 405-410.
26. Lewis, D. A., & Sherman, B. M. (1984). Serotonergic stimulation of adrenocorticotropin secretion in man. Journal of Clinical Endocrinology and Metabolism, 58, 458-462.
27. Lewis, D. A., & Sherman, B. M. (1985). Serotonergic regulation of prolactin and growth hormone secretion in man. Acta Endocrinologica, 110, 152-157.
28. Lichtenberg, P., Shapira, B., Gillon, D., Cooper, T. B., Newman, M. E., et al. (1992). Hormone responses to fenfluramine and placebo challenge in endogenous depression. Psychiatry Research, 43, 137-146.
29. Marcusson, J. O., Morgan, D. G., Winblad, B., & Finch, C. E. (1984). Serotonin receptors in aging human brain. Selective reduction of S-2A receptors in frontal cortex and hippocampus. Brain Research, 311, 51-57.
30. McBride, P. A., Tierney, H., DeMeo, M., Chen, J. S., & Mann, J. J. (1990). Effects of age and gender on CNS serotonergic responsivity in normal adults. Biological Psychiatry, 27, 1143-1155.
31. Meltzer, H. Y., & Lowy, M. T. (1987). The serotonin hypothesis of depression. In H. Meltzer (Ed.), Psychopharmacology: The third generation of progress (pp. 513-526). New York: Raven Press.
32. Meltzer, H. Y., Umberkoman-Wiita, B., Robertson, A.,Tricou, B. J., Lowy, M., et al. (1984). Effect of 5-hydroxytryptophan on serum Cortisol levels in major affective disorders: I. Enhanced response in depression and mania. Archives of General Psychiatry, 41, 366-374.
33. Mitchell, P., & Smythe, G. (1990). Hormonal responses to fenfluramine in depressed and control subjects. Journal of Affective Disorders, 19, 43-51.
34. Mitchell, P. B., & Smythe, G. A. (1991). Endocrine and amine responses to d,1-fenfluramine in normal subjects. Psychiatry Research, 39, 141-153.
35. Murphy, E. (1983). The prognosis of depression in old age. British Journal of Psychiatry, 142, 111-119.
36. O'Keane, V., & Dinan, T. G. (1991). Prolactin and cortisol responses to d-fenfluramine in major depression: Evidence for diminished responsivity of central serotonergic function. American Journal of Psychiatry, 148, 1009-1015.
37. Pare, C. M. B., Trenchard, A., & Turner, P. (1974). 5-Hydroxytryptamine in depression. Advances in Biochemical Psychopharmacology, 11, 275-279.
38. Paul, S. M., Rehavi, M., Skolnick, P., & Goodwin, F. K. (1984). High affinity binding of antidepressants to a biogenic amine transport site in human brain and platelet: Studies in depression. In R. M. Post & J. C. Ballenger (Eds.), Neurobiology of mood disorders (pp. 845-953). Baltimore: Williams & Wilkins.
39. Quattrone, A., Direnzo, G., Schettini, G., Tedeschi, G., & Scopacaso, F. (1978). Increased plasma prolactin levels induced by d-fenfluramine: Relation to central serotonergic stimulation. European Journal of Pharmacology, 49, 163-167.
40. Quattrone, A., Tedesci, G., Aguglia, F., Scopacasa, F., Direnzo, G. F., et al. (1983). Prolactin secretion in man: A useful tool to evaluate the activity of drugs on central 5-hydroxy tryptaminergic neurones: Studies with fenfluramine. British Journal of Clinical Pharmacology, 16, 471-475.
41. Sapolsky, R. M. (1987). Glucocorticoids and hippocampal damage. Trends in Neurosciences, 10, 346-349.
42. Sapolsky, R. M., Armanini, M., Packan, D., & Tombaugh, G. (1987). Stress and glucocorticoids in aging. Endocrinology and Metabolism Clinics of North America, 16, 965-980.
43. Seeman, T. E., & Robbins, R. J. (1994). Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocrine Reviews, 15, 233-250.
44. Shapira, B., Lerer, B., Kindler, S., Lichtenberg, P., Gropp, C., et al. (1992a). Enhanced serotonergic responsivity following electroconvulsive therapy in patients with major depression. British Journal of Psychiatry, 160, 223-229.
45. Shapira, B., Yagmur, M. J., Gropp, C., Newman, M. E., & Lerer, B. (1992b). Effect of clomipramine and lithium on fenfluramine-induced hormone release in major depression. Biological Psychiatry, 31, 975-983.
46. Siever, L. J., Murphy, D. L., Slater, S., De La Vega, E., & Lipper, S. (1984). Plasma prolactin changes following fenfluramine in depressed patients compared to controls: An evaluation of central serotonergic responsivity in depression. Life Sciences, 34, 1029-1039.
47. Spitzer, R. L., Endicott, J., & Robins, E. (1989). Research Diagnostic Criteria for a selected group of functional disorders. New York: New York Psychiatric Institute.
48. Stanley, M., & Mann, J. J. (1983). Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet, 1, 214-216.
49. Stanley, M., Viggilio, J., & Gershon, S. (1982). Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science, 216, 1337-1339.
50. Weizman, A., Mark, M., Gil-Ad, I., Tyano, S., & Laron, Z. (1988). Plasma cortisol, prolactin, growth hormone and immunoreactive B-endorphin response to fenfluramine challenge in depressed patients. Clinical Neuropharmacology, 11, 250-256.
51. Wong, D. F., Wagner, H. N., Dannals, R. F., Links, J. M., Frost, J. J., et al. (1984). Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science, 226, 1393-1396.